Saltar al contenido
Merck
  • Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

The Journal of surgical research (2013-05-28)
Ilhan Inci, Sven Hillinger, Stephan Arni, Tevfik Kaplan, Demet Inci, Walter Weder
RESUMEN

We tested whether an injured lung graft from category-3 donation after cardiac death donor could be reconditioned with an ex vivo lung perfusion (EVLP) system by intrabronchial diluted surfactant lavage before transplantation. In a pig model, cardiac arrest was induced by deconnecting from the ventilator. Left lung injury was done by intrabronchial instillation of 1 mL/kg pepsin + HCl. After retrieval, the heart-lung block was stored at 4°C for 2 h. In the treated group, transplantation was performed after reconditioning with intrabronchial diluted surfactant lavage in EVLP system. During EVLP, surfactant group showed better oxygenation and lower pulmonary vascular resistance. After transplantation, better oxygenation, lower mean pulmonary artery pressure, and lower lung edema were observed in surfactant group. Lower blood IL-1 beta and IL-6 cytokine levels were measured in the surfactant group. In bronchoalveolar lavage, the percentage of neutrophils, IL-1 beta and IL-6 cytokine levels, amount of protein, and neutrophil infiltration in the lung tissue at the end of the experiment were significantly lower in the surfactant group. Our data demonstrate the feasibility of reconditioning and transplantation of an acutely damaged lung graft due to aspiration from a category-3 DCD donor. Implementation of an EVLP system is an efficacious tool to recondition and assess a questionable graft before transplantation.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Ácido clorhídrico, ACS reagent, 37%
Sigma-Aldrich
Ácido clorhídrico, ACS reagent, 37%
Sigma-Aldrich
Cloruro de hidrógeno solution, 4.0 M in dioxane
Sigma-Aldrich
Pepsina from porcine gastric mucosa, powder, ≥250 units/mg solid
Sigma-Aldrich
Ácido clorhídrico solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Pepsina from porcine gastric mucosa, lyophilized powder, ≥3,200 units/mg protein
Sigma-Aldrich
Ácido clorhídrico, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
Ácido clorhídrico, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Cloruro de hidrógeno solution, 2.0 M in diethyl ether
Sigma-Aldrich
Ácido clorhídrico, 36.5-38.0%, BioReagent, Molecular Biology
Sigma-Aldrich
Pepsina from porcine gastric mucosa, powder, ≥400 units/mg protein
Supelco
Ácido clorhídrico solution, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Cloruro de hidrógeno solution, 1.0 M in diethyl ether
Sigma-Aldrich
Ácido clorhídrico solution, for amino acid analysis, ~6 M in H2O
Sigma-Aldrich
Cloruro de hidrógeno solution, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Ácido clorhídrico solution, 32 wt. % in H2O, FCC
Sigma-Aldrich
Pepsina from porcine gastric mucosa, powder, slightly beige, ≥500 U/mg
Sigma-Aldrich
Pepsina from porcine gastric mucosa, powder, slightly beige, 1200-2400 U/mg
Sigma-Aldrich
Cloruro de hidrógeno solution, 1.0 M in acetic acid
Supelco
Hydrogen chloride – ethanol, ~1.25 M HCl, derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
Pepsina from porcine gastric mucosa, tested according to Ph. Eur.
Sigma-Aldrich
Pepsin−Agarose from porcine gastric mucosa, lyophilized powder, ≥30 units/mg dry solid
Supelco
Hydrogen chloride - 1-butanol solution, ~3 M in 1-butanol, derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
Pepsina from porcine gastric mucosa, Suitable for manufacturing of diagnostic kits and reagents, lyophilized powder, ≥3200 units/mg protein